MDM2 and cancer: In 2013, Sheng, Zhang and co-workers reported the synthesis of a set of pyrrolo[3,4-c]pyrazole derivatives 197 that were excellent simultaneous inhibitors of p53-MDM2 and NF-κB (five DNA-binding proteins that are often hyperactive in cancer and inflammatory processes) [176].